Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Colon cancer: a new prognostic and predictive tool

Alberto F. Sobrero • 18 May 2020
ASCO 2020
Colorectal Cancer Gastrointestinal Cancer 5-fluorouracil Capecitabine Oxaliplatin

Alberto F. Sobrero, MD, Ospedale San Martino, Genova, Italy, describes a new prognostic and predictive tool to enhance shared decision-making in stage III colon cancer. Prof. Sobrero reveals that this toll gives patients and doctors the projected relative benefit of each treatment option and may significantly help the shared decision-making process. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Alberto F. Sobrero

10:27
Adjuvant treatment of colon cancer: three vs six months of FOLFOX/CAPOX
Alberto F. Sobrero • 18 May 2020
3:24
COVID-19 & the management of cancer patients
Alberto F. Sobrero • 3 Jun 2020

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals